Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure,...
-
Xeriant (OTCQB: XERI) launching NexPatch, a proprietary fire-resistant joint compound developed for use with its NEXBOARD composite construction panels.
-
TORONTO and HAIFA, Israel, Feb. 27, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing...
-
Brig. Gen. (Ret.) Blaine Holt assumed a strategic role aimed at expanding Xeriant’s (OTCQB: XERI) technology portfolio
-
Xeriant (OTCQB: XERI) successfully completed its September NEXBOARD production run
-
Xeriant (OTCQB: XERI) successfully completed its August production run of NEXBOARD, the Company’s next-generation eco-friendly composite construction panel
-
Xeriant (OTCQB: XERI) publishes a video showcasing the powerful performance of the Company’s nanotech fire-retardant.
-
Xeriant (OTCQB: XERI) appoints nanomaterials expert, Mark Sternberg, to its Board of Directors
-
Xeriant (OTCQB: XERI) enhances NEXBOARD™’s mechanical and thermal properties through the incorporation of nanotechnology
-
Xeriant (OTCQB: XERI) appoints nano-coatings and nanomaterial expert, Mark Sternberg, to the Company’s Advisory Board